ArticleHaematologica2023

Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimens.

Christopher E Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.